Delayed Nasdaq Stockholm 07:59:50 2024-03-28 am EDT 5-day change 1st Jan Change
47.2 SEK +5.10% Intraday chart for BICO Group AB +17.15% -17.13%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
BICO Group AB Announces Management Resignations CI
Transcript : BICO Group AB, Q4 2023 Earnings Call, Feb 20, 2024
BICO Group AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
BICO Group AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
BICO Group AB Announces Goodwill Impairment for the Fourth Quarter of 2023 CI
BICO Group AB Provides Preliminary Unaudited Financial Guidance for the Fourth Quarter and Full Year of 2023 CI
BICO Group AB Appoints Catharina Nordlund as Global Head of HR CI
Beos Light Industrial Germany 1 Fund managed by BEOS AG completed the acquisition of property on Wagner-Régeny-Straße 15 from BICO Group AB (OM:BICO) for ?21 million. CI
BICO's New CEO/President to Assume Roles Nov. 20 MT
Transcript : BICO Group AB, Q3 2023 Earnings Call, Nov 14, 2023
BICO Group AB Announces the Appointment of Nomination Committee CI
BICO Group AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BICO Group AB Appoints Maria Forss Assumes Office as President CI
BICO Group AB Appoints Maria Forss as CEO, Effective from on November 20, 2023 CI
Bico Group Divests Ginolis in EUR1 Management Buyout Deal MT
Kauko Väinämö acquired Ginolis Ltd from BICO Group AB (OM:BICO) for ?1. CI
Transcript : BICO Group AB - Special Call
Transcript : BICO Group AB, Q2 2023 Earnings Call, Aug 22, 2023
BICO Group AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
BICO Group's President, CEO Resigns; Vitrolife Exec Named Successor MT
Maria Forss has acquired 0.028 million shares in BICO Group AB. CI
BICO Group AB Resolves to Write-Down Goodwill for the Second Quarter of 2023 CI
BICO Group AB Announces Chief Executive Officer Changes CI
BICO Group AB Announces President Changes CI
Bico Group Sells German Property for EUR21 Million MT
Chart BICO Group AB
More charts
Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company's operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
44.91 SEK
Average target price
132.5 SEK
Spread / Average Target
+195.03%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock BICO Group AB - Nasdaq Stockholm
  4. News BICO Group AB
  5. Bico : Buys US Life Sciences Company Hurel for $2.5 Million